![]() |
市场调查报告书
商品编码
1744534
2032 年熊果酸市场预测:按产品类型、萃取、纯度等级、形态、应用和地区进行的全球分析Ursolic Acid Market Forecasts to 2032 - Global Analysis By Product Type, Extraction, Purity Level, Form, Application and By Geography |
根据 Stratistics MRC 的数据,全球熊果酸市场预计在 2025 年达到 3.7643 亿美元,到 2032 年达到 6.0051 亿美元,预测期内的复合年增长率为 6.9%。
熊果酸是一种天然化合物,存在于各种水果、香草和植物的蜡质外皮中,包括苹果、迷迭香、百里香和罗勒。它以其丰富的生物活性而闻名,是一种三萜化合物。熊果酸因其潜在的健康益处而备受关注,包括抗发炎、抗氧化、抗癌和抗菌特性。此外,人们也正在研究熊果酸在心血管健康、减少脂肪储存和促进肌肉生长方面的潜力。这些特性使其在药品、化妆品和膳食补充剂中的应用日益广泛。
根据发表在《药理学前沿》上的一项综合统合分析,熊果酸 (UA) 显着降低促炎细胞激素,例如 IL-1β、IL-6 和 TNF-α,同时增强氧化酵素,例如 SOD 和 GSH。这些发现表明,UA 可能具有治疗与慢性发炎和氧化压力相关的病理的潜力。
人们对天然植物来源的兴趣日益浓厚
熊果酸市场很大程度上受到全球对天然、植物来源和永续成分的追求的推动。尤其是在已开发国家,人们越来越倾向于在食品、化妆品和补充剂产品中使用植物来源成分而非合成化学物质。熊果酸是一种天然存在的三萜类化合物,存在于苹果皮、迷迭香、百里香和圣罗勒等草本植物中,完美地满足了这项需求。此外,人们对环境永续性以及合成成分的长期健康影响日益增长的担忧,也助长了人们对天然化合物的青睐。
溶解性差,生物利用度低
熊果酸的一个主要缺点是口服生物利用度低。儘管熊果酸具有良好的药理特性,但它在胃肠道的吸收有限,且难溶于水。因此,只有一小部分活性化合物进入体循环,降低了其在临床和治疗应用中的疗效。此外,为了解决这些问题,人们探索了脂质体、奈米颗粒和固体分散体等新的递送方法,但由于製造成本和复杂性的增加,这些产品的上市难度加大。
肌肉健康和运动营养的当前趋势
熊果酸已被证实具有促进肌肉生长和减少脂肪的功效,在运动营养和积极生活方式产品日益普及的背景下,熊果酸代表着巨大的市场机会。研究表明,熊果酸能够增强IGF-1讯号传导并抑制肌肉萎缩途径,这使其对运动员、健身爱好者以及希望保持肌肉质量的老年人群体极具吸引力。从事高强度运动和阻力训练的消费者也可能被熊果酸所吸引。此外,随着全球运动营养市场(尤其是在美国、欧洲和亚太地区)的成长,製造商可以将熊果酸定位为一种新型植物来源运动表现增强成分。
与其他天然物质的激烈竞争
来自白藜芦醇、姜黄素、槲皮素和绿茶儿茶素等其他知名天然生物活性成分的竞争是熊果酸市场面临的最大风险之一。这些物质在製药、营养保健品和化妆品行业中已经享有强大的消费者信任、强大的品牌认知度和坚实的科学支持。它们通常也比熊果酸拥有更高的监管认可度和更高的生物利用度。此外,产品开发人员在配製产品时通常会优先考虑这些替代品。在这种竞争激烈的环境中,除非熊果酸在功效、安全性和给药系统方面展现出显着且独特的优势,否则其市场占有率将会下降。
新冠疫情对熊果酸市场产生了多方面的影响。最初,由于劳动力短缺、供应链中断以及原材料开采受限,熊果酸的生产和分销受到了延迟,尤其是中小型製造商。然而,随着疫情蔓延,消费者对天然免疫增强剂和健康补充剂的兴趣显着增长,推动了熊果酸相关产品的发展。熊果酸潜在的抗炎、抗病毒和维持肌肉力量的特性使其在新冠疫情期间的康復和健康护理中广受欢迎,从而刺激了机能性食品和膳食补充剂行业的需求。
溶剂萃取领域预计将成为预测期内最大的领域
预计溶剂萃取领域将在预测期内占据最大的市场占有率。这种方法简单、经济实惠且扩充性,使其在工业应用中广受欢迎。使用乙醇和甲醇等有机溶剂,可以高效地从苹果皮、迷迭香和罗勒等天然来源中提取熊果酸。这种方法可以实现高提取率和效率,使其适用于製药、化妆品和营养保健品领域的商业化生产。此外,儘管人们对绿色技术的兴趣日益浓厚,但溶剂萃取凭藉其完善的通讯协定、价格合理的设备以及适合大批量加工的优势,尤其是在开发中国家和中型生产企业中,仍然保持着主导地位。
预计膳食补充剂领域在预测期内将出现最高的复合年增长率。
预计营养保健品领域将在预测期内达到最高成长率。消费者对促进肌肉健康、体重管理和免疫力的天然植物补充剂的需求不断增长,这推动了这一增长。熊果酸因其强大的抗发炎和抗氧化特性,已成为机能性食品、胶囊和膳食补充剂的常见成分。新冠疫情后的健康机芯进一步推动了这一需求,尤其是在老年人和注重健身的人群中。此外,随着预防性医疗保健在全球范围内日益普及,营养保健品公司正在将熊果酸添加到其多成分配方中,从而刺激创新和市场成长。
预计亚太地区将在预测期内占据最大的市场占有率。这可以归因于熊果酸在传统医学中的广泛应用、人们对天然保健品日益增长的兴趣以及化妆品和製药行业的蓬勃发展。中国、印度和日本等国家凭藉其丰富的熊果酸植物供应以及政府对草药产品开发的大力支持,处于领先地位。消费者对护肤品和膳食补充剂中天然和有机成分的偏好日益增长,也刺激了市场扩张。此外,该地区在全球熊果酸市场的主导地位也因人们健康意识的增强和可支配收入的增加而进一步巩固。
预计欧洲地区在预测期内的复合年增长率最高。推动这一成长的关键因素是提取技术的进步,这些技术提高了熊果酸生产流程的扩充性和成本效益。现在,这种化合物更容易用于研究,尤其是在探索其潜在的抗癌特性方面。欧洲製药业正在积极探索熊果酸的治疗用途,这推动了该地区市场的快速成长。此外,预计欧洲将在预测期内引领市场成长率。
According to Stratistics MRC, the Global Ursolic Acid Market is accounted for $376.43 million in 2025 and is expected to reach $600.51 million by 2032 growing at a CAGR of 6.9% during the forecast period. Ursolic acid is a naturally occurring compound found in the waxy coatings of various fruits, herbs, and plants, such as apples, rosemary, thyme, and basil. It is well-known for its diverse range of biological activities and is a member of the triterpene class. Because of its potential health benefits, such as its anti-inflammatory, antioxidant, anti-cancer, and antimicrobial qualities, ursolic acid has gained attention. It is also being investigated for its potential to support cardiovascular health, decrease fat accumulation, and encourage muscle growth. Moreover, these characteristics have led to ursolic acid's growing use in pharmaceutical, cosmetic, and dietary supplement formulations.
According to a comprehensive meta-analysis published in Frontiers in Pharmacology, ursolic acid (UA) significantly reduces pro-inflammatory cytokines such as IL-1B, IL-6, and TNF-a, while enhancing antioxidant enzymes like SOD and GSH. These findings suggest UA's potential in managing conditions associated with chronic inflammation and oxidative stress.
Growing interest in plant-based and natural ingredients
The market for ursolic acid is largely driven by the worldwide trend toward natural, plant-based, and sustainable ingredients. Customers are increasingly choosing botanical substitutes for synthetic chemicals in food, cosmetics, and supplement products, especially in developed nations. This requirement is perfectly met by ursolic acid, a naturally occurring triterpenoid that can be found in apple peels, rosemary, thyme, holy basil, and other herbs. Additionally, growing concerns about the sustainability of the environment and the long-term health effects of synthetic ingredients are also contributing to the trend toward a preference for naturally sourced compounds.
Insufficient solubility and low bioavailability
A major drawback of ursolic acid is that it has a low bioavailability when taken orally. Although ursolic acid has promising pharmacological qualities, it has limited absorption in the gastrointestinal tract and is poorly soluble in water. As a result, only a small portion of the active compound enters the systemic circulation, rendering it much less effective in clinical or therapeutic applications. Furthermore, new delivery methods such as liposomes, nanoparticles, and solid dispersions are being looked at to solve these issues; however, they also increase production costs and complexity, making it harder to sell these products.
Recent developments in muscle health and sports nutrition
Due to its demonstrated capacity to promote muscle growth and decrease fat mass, ursolic acid has a significant opportunity as sports nutrition and active lifestyle products gain popularity. Urosolic acid is appealing to athletes, fitness enthusiasts, and older populations looking to preserve muscle mass because studies have demonstrated that it increases IGF-1 signaling and inhibits muscle atrophy pathways. Customers who do high-intensity exercises or resistance training might also find it appealing. Moreover, ursolic acid can be positioned by manufacturers as a new plant-based performance-enhancing ingredient as the global sports nutrition market grows, especially in the U.S., Europe, and Asia-Pacific.
Strong competition from other natural substances
Strong competition from other well-known natural bioactive ingredients, like resveratrol, curcumin, quercetin, and green tea catechins, is one of the biggest risks facing the ursolic acid market. In the pharmaceutical, nutraceutical, and cosmetic industries, these substances already enjoy strong consumer trust, strong brand awareness, and solid scientific support. Compared to ursolic acid, many of them also have higher regulatory acceptance and superior bioavailability. Furthermore, product developers frequently give these alternatives top priority when it comes to formulation inclusion. Ursolic acid's market share is diminished by this fiercely competitive environment unless it can show notable and distinctive benefits in terms of efficacy, safety, or delivery systems.
The COVID-19 pandemic affected the ursolic acid market in a variety of ways. At first, production and distribution were delayed, especially for small and medium-sized manufacturers, due to labour shortages, supply chain disruptions, and restrictions on the harvesting of raw materials. However, there was a noticeable increase in consumer interest in natural immunity enhancers and health-boosting supplements as the pandemic spread, which encouraged the development of ursolic acid-based products. Due to its possible anti-inflammatory, antiviral, and muscle-preserving qualities, it gained popularity in the context of COVID-19 recovery and wellness regimens, which raised demand in the functional food and nutraceutical industries.
The solvent extraction segment is expected to be the largest during the forecast period
The solvent extraction segment is expected to account for the largest market share during the forecast period. The simplicity, affordability, and scalability of this approach make it popular for industrial applications. Ursolic acid can be efficiently extracted from natural sources such as apple peels, rosemary, and basil by employing organic solvents like ethanol or methanol. High extraction yields and efficiency are made possible by it, which makes it appropriate for commercial production in the pharmaceutical, cosmetic, and nutraceutical sectors. Moreover, solvent extraction continues to dominate despite growing interest in greener technologies due to its well-established protocols, affordable equipment, and suitability for large-volume processing, particularly in developing nations and mid-sized manufacturing facilities.
The nutraceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the nutraceuticals segment is predicted to witness the highest growth rate. The rising demand from consumers for natural, plant-based supplements that promote muscle health, weight management, and immunity is what is fueling this expansion. Ursolic acid is a common component of functional foods, capsules, and dietary supplements due to its strong anti-inflammatory and antioxidant qualities. This need has increased even more as a result of the post-COVID-19 wellness movement, particularly among older and fitness-conscious populations. Additionally, nutraceutical companies are adding ursolic acid to multi-ingredient formulas as preventive healthcare gains popularity worldwide, spurring innovation and market growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by its widespread application in conventional medicine, rising interest in natural health supplements, and the growth of the cosmetics and pharmaceutical industries. Because of their plentiful supply of plants high in ursolic acid and their robust government support for the development of herbal products, nations like China, India, and Japan are at the forefront. Market expansion is also fueled by consumers' growing preference for natural and organic ingredients in skincare products and dietary supplements. Furthermore, the region's dominance in the global ursolic acid market is further supported by its growing health-conscious population and rising disposable income.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR. The main factor driving this growth is the development of extraction technologies that improve the ursolic acid production process's scalability and cost-effectiveness. For research purposes, especially in examining its possible anti-cancer properties, this compound is now more easily accessible. Europe's pharmaceutical sector is actively researching the therapeutic uses of ursolic acid, which is helping the region's market grow quickly. Moreover, Europe is therefore anticipated to lead the market growth rate over the course of the forecast period.
Key players in the market
Some of the key players in Ursolic Acid Market include Hunan NutraMax Inc., Cayman Chemical Company, Inc., Acetar Bio-Tech Inc, Merck KGaA, Sabinsa Corporation, Geneham Pharmaceutical Inc, TCI Chemicals Pvt. Ltd., Changsha Staherb Natural Ingredients, Shaanxi Jintai Biological Engineering Inc and Changsha E.K HERB.
In April 2025, Merck KGaA and SpringWorks Therapeutics Inc have entered into a definitive agreement for Merck KGaA, Darmstadt, Germany, to acquire SpringWorks. The agreed acquisition of SpringWorks is a major step in our active portfolio strategy to position our company as a globally diversified, innovation and technology powerhouse.
In October 2024, Sabinsa Corporation and Postbiotics, Inc announced a multinational distribution agreement for the dietary supplement and functional food ingredient PoZibio(R) for age-related digestive health conditions including Leaky Gut Syndrome (LGS).
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.